rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Norma Ann Provencio

Director

Company insider

Files Form 4 as: Director, Beazer Homes USA; Director, Bausch Health Companies; Director, Valeant Pharmaceuticals International.

In numbers

Trades disclosed
130
Buys
13
Sells
8
Bought
$906K
Sold
$4.7M
Companies
3
Companies where not an officer
3
First trade
22 May 2007
Last trade
20 Oct 2026
Last filed
20 Oct 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
Beazer Homes USADirector · Homebuilders · last 20 Oct 20264 buys · 0 sells
BHC Bausch Health CompaniesDirector · Pharmaceuticals · last 2 May 20167 buys · 8 sells
Valeant Pharmaceuticals InternationalDirector · last 28 Sep 20102 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
01Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
20 Oct 2026filed 20 Oct 2026Beazer Homes USAHomebuildersSEC FORM 4 Code D—98,189filing
20 Oct 2026filed 20 Oct 2026Beazer Homes USAHomebuildersSEC FORM 4 Code D—10,600filing
20 Oct 2026filed 20 Oct 2026Beazer Homes USAHomebuildersSEC FORM 4 Code D—7,199filing
17 Nov 2025filed 18 Nov 2025Beazer Homes USAHomebuildersSEC FORM 4 Code A—7,199 at $0.00filing
10 Feb 2025filed 10 Feb 2025Beazer Homes USAHomebuildersSEC FORM 4 Bought$110K5,000 at $21.93filing
15 Nov 2024filed 19 Nov 2024Beazer Homes USAHomebuildersSEC FORM 4 Code A—5,051 at $0.00filing
20 Nov 2023filed 21 Nov 2023Beazer Homes USAHomebuildersSEC FORM 4 Code A—6,024 at $0.00filing
14 Nov 2022filed 16 Nov 2022Beazer Homes USAHomebuildersSEC FORM 4 Code A—14,181 at $0.00filing
12 Nov 2021filed 16 Nov 2021Beazer Homes USAHomebuildersSEC FORM 4 Code A—7,679 at $0.00filing
16 Nov 2020filed 18 Nov 2020Beazer Homes USAHomebuildersSEC FORM 4 Code A—9,177 at $0.00filing
15 Nov 2019filed 19 Nov 2019Beazer Homes USAHomebuildersSEC FORM 4 Code A—8,002 at $0.00filing
15 Nov 2018filed 19 Nov 2018Beazer Homes USAHomebuildersSEC FORM 4 Code A—10,183 at $0.00filing
16 Nov 2017filed 17 Nov 2017Beazer Homes USAHomebuildersSEC FORM 4 Code A—4,887 at $0.00filing
17 Nov 2016filed 21 Nov 2016Beazer Homes USAHomebuildersSEC FORM 4 Code A—7,993 at $0.00filing
17 Nov 2016filed 17 Nov 2016Beazer Homes USAHomebuildersSEC FORM 4 Code A—7,993 at $0.00filing
2 May 2016filed 4 May 2016BHC Bausch Health CompaniesPharmaceuticalsSEC FORM 4 Code A—1,188 at $0.00filing
31 Dec 2015filed 4 Jan 2016BHC Bausch Health CompaniesPharmaceuticalsSEC FORM 4 Code A—344 at $0.00filing
12 Nov 2015filed 16 Nov 2015Beazer Homes USAHomebuildersSEC FORM 4 Code A—7,128 at $0.00filing
30 Sep 2015filed 2 Oct 2015BHC Bausch Health CompaniesPharmaceuticalsSEC FORM 4 Code A—196 at $0.00filing
30 Jun 2015filed 2 Jul 2015BHC Bausch Health CompaniesPharmaceuticalsSEC FORM 4 Code A—157 at $0.00filing

News

Contrasting Ocular Therapeutix (NASDAQ:OCUL) and Bausch Health Cos (NYSE:BHC)BHC · dailypolitical.com · 13 Oct 2026

0 headlines in the last 90 days name Norma Ann Provencio; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.

Sectors

Health Care15
Consumer Discretionary4
Not placed2

Buys in green, sells in red, by the company’s sector.

Related people

Michael Anthony DunnSVP, GC and Corp Secretary · SVP, GC and Corp Secretary at Beazer Homes USA, filing Form 4 there in the last year
C. Christian WinkleDirector · Director at Beazer Homes USA, filing Form 4 there in the last year
Allan P. MerrillChairman, President and CEO · Chairman, President and CEO at Beazer Homes USA, filing Form 4 there in the last year
Peter M. OrserDirector · Director at Beazer Homes USA, filing Form 4 there in the last year
John J. Kelley IIIDirector · Director at Beazer Homes USA, filing Form 4 there in the last year
Aimee J. LenarPresident, US Pharma · Also traded BHC in the last 90 days